×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EXAS – exact sciences corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EXAS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/27
08:02 am
exas
Exact Sciences Corp. (EXAS) Rose Following the Acquisition Announcement [Yahoo! Finance]
Low
Report
Exact Sciences Corp. (EXAS) Rose Following the Acquisition Announcement [Yahoo! Finance]
1/26
03:56 am
exas
Alger Small Cap Growth Fund Q4 2025 Portfolio Update [Seeking Alpha]
Low
Report
Alger Small Cap Growth Fund Q4 2025 Portfolio Update [Seeking Alpha]
1/24
07:11 pm
exas
A Look At Exact Sciences (EXAS) Valuation After Its Strong Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Look At Exact Sciences (EXAS) Valuation After Its Strong Recent Share Price Momentum [Yahoo! Finance]
1/22
12:27 pm
exas
Abbott posts Q4 sales below expectations [Yahoo! Finance]
Low
Report
Abbott posts Q4 sales below expectations [Yahoo! Finance]
1/21
04:52 pm
exas
Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights
1/21
03:58 pm
exas
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS
1/21
06:19 am
exas
Exact Sciences (NASDAQ:EXAS) was downgraded by analysts at Mizuho from a "strong-buy" rating to a "hold" rating.
Low
Report
Exact Sciences (NASDAQ:EXAS) was downgraded by analysts at Mizuho from a "strong-buy" rating to a "hold" rating.
1/20
07:17 am
exas
Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Mizuho.
Low
Report
Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Mizuho.
Date
Time
Symbol
Company Name
Action
%Chg
11/3/2025
04:05 pm
exas
exact sciences corporation
BEAT
Report
3.9%
exact sciences corporation
8/6/2025
04:05 pm
exas
exact sciences corporation
BEAT
Report
-8.0%
exact sciences corporation
5/1/2025
04:05 pm
exas
exact sciences corporation
MISS
Report
9.3%
exact sciences corporation
2/19/2025
04:05 pm
exas
exact sciences corporation
MISS
Report
-3.1%
exact sciences corporation
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/30
04:01 pm
exas
Form DEFA14A EXACT SCIENCES CORP
Low
Report
Form DEFA14A EXACT SCIENCES CORP
1/23
06:05 am
exas
Form DEFA14A EXACT SCIENCES CORP
Low
Report
Form DEFA14A EXACT SCIENCES CORP
1/9
08:16 am
exas
Form DEFM14A EXACT SCIENCES CORP
Low
Report
Form DEFM14A EXACT SCIENCES CORP
12/30
04:30 pm
exas
Form 4 EXACT SCIENCES CORP For: Dec 23 Filed by: Bloomer Aaron
Low
Report
Form 4 EXACT SCIENCES CORP For: Dec 23 Filed by: Bloomer Aaron
12/30
04:30 pm
exas
Form 4 EXACT SCIENCES CORP For: Dec 23 Filed by: Conroy Kevin T
Low
Report
Form 4 EXACT SCIENCES CORP For: Dec 23 Filed by: Conroy Kevin T
12/30
04:30 pm
exas
Form 4 EXACT SCIENCES CORP For: Dec 23 Filed by: Herriott James
Low
Report
Form 4 EXACT SCIENCES CORP For: Dec 23 Filed by: Herriott James
12/30
04:30 pm
exas
Form 4 EXACT SCIENCES CORP For: Dec 23 Filed by: Baranick Brian
Low
Report
Form 4 EXACT SCIENCES CORP For: Dec 23 Filed by: Baranick Brian
12/30
04:30 pm
exas
Form 4 EXACT SCIENCES CORP For: Dec 23 Filed by: Condella Sarah
Low
Report
Form 4 EXACT SCIENCES CORP For: Dec 23 Filed by: Condella Sarah
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/19
Exact Sciences takes action during COVID-19 pandemic [Seeking Alpha]
37.6%
7/29 UPDATE 2-Diagnostic company Exact Sciences to buy Genomic Health in $2.8 bln deal [Reuters] 15.2%
4/3 Fulgent Genetics Is Fundamentally Sound [Seeking Alpha] 10.8%
4/16 2 Stocks That Could Double Your $1,200 Stimulus Check [The Motley Fool] 10.0%
4/8 Exact Sciences schedules first-quarter 2020 earnings call 7.2%
10/3 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 7.1%
11/8 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.6%
2/11 Form 8-K EXACT SCIENCES CORP For: Feb 11 6.5%
4/24 Form 3 EXACT SCIENCES CORP For: Apr 22 Filed by: Lewis-Hall Freda C 6.4%
10/14 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 6.0%
7/29 UPDATE 2-Diagnostic company Exact Sciences to buy Genomic Health in $2.8 bln deal [Reuters] 15.2%
4/3 Fulgent Genetics Is Fundamentally Sound [Seeking Alpha] 10.8%
4/16 2 Stocks That Could Double Your $1,200 Stimulus Check [The Motley Fool] 10.0%
4/8 Exact Sciences schedules first-quarter 2020 earnings call 7.2%
10/3 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 7.1%
11/8 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.6%
2/11 Form 8-K EXACT SCIENCES CORP For: Feb 11 6.5%
4/24 Form 3 EXACT SCIENCES CORP For: Apr 22 Filed by: Lewis-Hall Freda C 6.4%
10/14 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 6.0%
TOP News Decliners
3/14
EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating.
-21.6%
1/12 Exact Sciences Announces Preliminary Fourth Quarter 2019 Results -13.8%
3/11 Why Exact Sciences, HealthEquity, and Senseonics Holdings Stocks Tanked Today [The Motley Fool] -12.7%
2/26 Exact Sciences to participate in March investor conferences -7.7%
3/3 Investors Should Revisit Exact Sciences Now [The Motley Fool] -7.5%
10/29 Q3/2019 9/30/2019 EPS -0.310 ZacksConsensus -0.410 ActVsEst 0.100 - Beat -7.3%
2/24 Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028 -6.9%
10/22 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.4%
8/2 Form 4 EXACT SCIENCES CORP For: Jul 31 Filed by: LEVANGIE DANIEL J -5.7%
9/23 EXACT Sciences Co. (NASDAQ: EXAS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. -5.4%
1/12 Exact Sciences Announces Preliminary Fourth Quarter 2019 Results -13.8%
3/11 Why Exact Sciences, HealthEquity, and Senseonics Holdings Stocks Tanked Today [The Motley Fool] -12.7%
2/26 Exact Sciences to participate in March investor conferences -7.7%
3/3 Investors Should Revisit Exact Sciences Now [The Motley Fool] -7.5%
10/29 Q3/2019 9/30/2019 EPS -0.310 ZacksConsensus -0.410 ActVsEst 0.100 - Beat -7.3%
2/24 Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028 -6.9%
10/22 EXACT Sciences Co. (NASDAQ: EXAS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.4%
8/2 Form 4 EXACT SCIENCES CORP For: Jul 31 Filed by: LEVANGIE DANIEL J -5.7%
9/23 EXACT Sciences Co. (NASDAQ: EXAS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. -5.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: